Literature DB >> 21831723

Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management.

Theresa Shao1, Michael L Grossbard, Paula Klein.   

Abstract

Testosterone is important for the development of secondary sexual characteristics in female-to-male (FtM) transsexuals, but it may increase breast cancer risk. To date, only one breast cancer case has been reported in the literature in a FtM transsexual after 10 years of testosterone therapy. We describe 2 cases of breast cancers diagnosed in FtM transsexuals who have been treated with supraphysiological doses of testosterone. Our 2 cases demonstrate the unique issues that concern the management of FtM transsexuals with breast cancer and examine possible roles of testosterone in the development of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21831723     DOI: 10.1016/j.clbc.2011.06.006

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  15 in total

Review 1.  Cross-sex hormone therapy for gender dysphoria.

Authors:  B Fabris; S Bernardi; C Trombetta
Journal:  J Endocrinol Invest       Date:  2014-11-18       Impact factor: 4.256

Review 2.  Cancer in Transgender People: Evidence and Methodological Considerations.

Authors:  Hayley Braun; Rebecca Nash; Vin Tangpricha; Janice Brockman; Kevin Ward; Michael Goodman
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

Review 3.  Endocrine treatment of aging transgender people.

Authors:  Louis J Gooren; Guy T'Sjoen
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

Review 4.  Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature.

Authors:  Julia Eismann; Yujing J Heng; Kristin Fleischmann-Rose; Adam M Tobias; Jordana Phillips; Gerburg M Wulf; Kari J Kansal
Journal:  Clin Breast Cancer       Date:  2018-11-14       Impact factor: 3.225

5.  SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people.

Authors:  A D Fisher; G Senofonte; C Cocchetti; G Guercio; V Lingiardi; M C Meriggiola; M Mosconi; G Motta; J Ristori; A M Speranza; M Pierdominici; M Maggi; G Corona; F Lombardo
Journal:  J Endocrinol Invest       Date:  2021-10-22       Impact factor: 4.256

6.  Profile of Male Breast Cancer in Makkah Region of Saudi Arabia: A 4-Year Retrospective Analysis of Radiology and Histopathology.

Authors:  Muhammad Saeed; Bothaina Mohammed Abdulshakour; Najwa Abdalkabeer A Bantan; Afnan Hisham Falemban; Munir Abdulla; Ehab M Melibary; Ahmad H Mufti; Mohiuddin M Taher
Journal:  Int J Breast Cancer       Date:  2022-06-22

7.  Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy.

Authors:  Dejan V Nikolic; Miroslav L Djordjevic; Miroslav Granic; Aleksandra T Nikolic; Violeta V Stanimirovic; Darko Zdravkovic; Svetlana Jelic
Journal:  World J Surg Oncol       Date:  2012-12-28       Impact factor: 2.754

8.  Cancer's Margins: Trans* and Gender Nonconforming People's Access to Knowledge, Experiences of Cancer Health, and Decision-Making.

Authors:  Evan T Taylor; Mary K Bryson
Journal:  LGBT Health       Date:  2015-11-13       Impact factor: 4.151

9.  Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals.

Authors:  Jamie D Weinand; Joshua D Safer
Journal:  J Clin Transl Endocrinol       Date:  2015-06

Review 10.  Breast Imaging of Transgender Individuals: A Review.

Authors:  Emily B Sonnenblick; Ami D Shah; Zil Goldstein; Tamar Reisman
Journal:  Curr Radiol Rep       Date:  2018-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.